[1] VUICHOUD C, LOUGHLIN K. Benign prostatic hyperplasia: epidemiology, economics and evaluation[J]. Can J Urol, 2015,22(Suppl 1):1-6.
[2] WEI J T, CALHOU E, JACOBSEN S J. Urologic diseases in America project: benign prostatic hyperplasia[J]. J Urol,2005,173(4):1256-1261.
[3] BECHIS S K, OTSETOV A G, GE R, et al. Personalized medicine for the management of benign prostatic hyperplasia[J]. J Urol,2014,192(1):16-23.
[4] 孙自学,李鹏超. 中医药治疗良性前列腺增生症研究进展[J]. 中华中医药杂志,2018,33(6):2482-2484.
[5] 孙自学,宋春生,邢俊平,等. 良性前列腺增生中西医结合诊疗指南(试行版)[J]. 中华男科学杂志,2017,23(3):280-285.
[6] 饶志, 张帆, 董毓松, 等. 栀子“辨状论质”及其品质成因研究进展[J]. 中草药, 2023, 54(6): 1998-2004.
[7] TIAN J, QIN S, HAN J, et al. A review of the ethnopharmacology, phytochemistry, pharmacology and toxicology of Fructus Gardeniae (Zhi-zi)[J]. J Ethnopharmacol,2022,289:114984.
[8] LIU H, ZHANG Z, ZANG C, et al. GJ-4 ameliorates memory impairment in focal cerebral ischemia/reperfusion of rats via inhibiting JAK2/STAT1-mediated neuroinflammation[J]. J Ethnopharmacol,2021,267:113491.
[9] XIA B, HUANG X, SUN G, et al. Iridoids from Gardeniae fructus ameliorates depression by enhancing synaptic plasticity via AMPA receptor-mTOR signaling[J]. J Ethnopharmacol,2020,268:113665.
[10] FAN Y L, LI X Y, DING L, et al. Accelerated solventextraction of antioxidant compounds from Gardeniae Fructus and its acetylcholi-nesterase inhibitory and PC12 cell protective activities[J]. Foods, 2021,10(11): 2805.
[11] OZAKI A, KITANO M, FURUSAWA N, et al. Genotoxicity of gardenia yellow and its components[J]. Food ChemToxicol, 2002, 40(11): 1603-1610.
[12] ZHANG N, LUO M, HE L, et al. Chemical composition of essential oil from flower of ‘shanzhizi’ (Gardeniajasminoides Ellis) and involvement of serotonergic systemin its anxiolytic effect[J]. Molecu-les, 2020, 25(20): 4702.
[13] 陈少峰,耿强,赵丰,等. 当归贝母苦参丸治疗良性前列腺增生的作用机制研究[J]. 南开大学学报(自然科学版),2022,55(6):23-30.
[14] 巩瑛杰,张奇,朱玉新,等. 益肾化瘀方药联合盐酸坦索罗辛治疗良性前列腺增生的Meta分析[J]. 中国新药杂志,2024,33(9):942-951.
[15] 吕璞,陆永辉,国文豪,等. 陆永辉分层针刺任脉经穴治疗良性前列腺增生临床经验[J]. 中国针灸,2024,44(5):569-573.
[16] 杨九天,郭军,高庆和,等. 基于“脏腑别通”理论探讨男性下尿路症状的证治[J]. 北京中医药大学学报,2024,47(3):302-306.
[17] STEINER G E, NEWMAN M E, PAIKL D, et al. Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate[J]. Prostate,2003,56(3):171-182.
[18] 高锐,刘启祥,周辉良,等. IL-17和IL-8在单纯BPH与合并炎症BPH患者前列腺组织中的表达[J]. 中华男科学杂志,2017,23(8):697-702.
[19] SREENIVASULU K, NANDEESHA H, DORAIRAJAN L N, et al. Over expression of PI3K-AkT reduces apoptosis and increases prostate size in benign prostatic hyperplasia[J]. Aging Male,2020, 23(5):440-446.
[20] Li S H, Ryu J H, Park S E, et al. Vitamin C supplementation preve-nts testosterone-induced hyperplasia of rat prostate by down-regulating HIF-1alpha[J]. J Nutr Biochem,2010,21(9):801-808.
[21] QI J, XIAN XH, LI L, et al. Sulbactam protects hippocampal neurons against oxygen-glucose deprivation by up-regulating astrocytic GLT-1 via p38 MAPK signal pathway[J]. Front Mol Neurosci,2018, 11:281.
[22] POPOVICS P, AWADALLAH W N, KOHRT S E, et al. Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia[J]. Prostate,2020,80(10):731-741.
[23] 孟繁超,李海松,赵琦,等. 灵泽片治疗良性前列腺增生症真实世界临床应用的疗效观察[J]. 中国男科学杂志,2021,35(4):40-44.
[24] 王晓航,王乐,肖銮娟,等. 芒柄花黄素通过雌激素受体抑制前列腺增生(英文)[J]. 中国药学,2024,33(3):216-229.